
USP and Icesp researchers develop BreastOncoPredict, an Artificial Intelligence software to predict the risk of recurrence or death in breast cancer patients
Software developed by USP and Icesp researchers uses routine blood test data to predict breast cancer recurrence risk, with the potential to expand access to prognostic assessment in Brazil’s public healthcare system









